Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 52.23M | $296.0M | 15.07% | +240.7K | 2026-06-30 |
| BlackRock, Inc. | 27.63M | $156.0M | 7.97% | +2.53M | 2026-06-30 |
| Decheng Capital LLC | 25.95M | $147.0M | 7.49% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.92M | $67.0M | 3.44% | +293.3K | 2026-06-30 |
| Omega Fund Management, LLC | 8.08M | $45.0M | 2.33% | -- | 2026-06-30 |
| Laurion Capital Management LP | 7.82M | $44.0M | 2.26% | -2.6K | 2026-06-30 |
| UBS Group AG | 7.49M | $42.0M | 2.16% | +6.12M | 2026-06-30 |
| STATE STREET CORP | 7.37M | $41.0M | 2.13% | +585.9K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 6.24M | $35.0M | 1.80% | +381.2K | 2026-06-30 |
| Duquesne Family Office LLC | 4.54M | $25.0M | 1.31% | -- | 2026-06-30 |
